Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 65 of 65 entries
View as:

Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery

Phase: N/A Priority: Normal
NCT ID: NCT04391049 Org: User:
Start: 12/02/21 End: 10/01/25 Due: 10/01/26

Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03367702 Org: User:
Start: 11/16/17 End: 12/31/30 Due: 12/31/31

Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol

Phase: N/A Priority: Normal
NCT ID: NCT03997370 Org: User:
Start: 01/15/20 End: 02/06/28 Due: 02/06/29

Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02254278 Org: User:
Start: 10/31/14 End: 05/31/25 Due: 05/31/26

Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03070886 Org: User:
Start: 04/05/17 End: 05/31/26 Due: 05/31/27

Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT02360215 Org: User:
Start: 07/31/15 End: 08/26/19 Due: 08/26/20

Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02186847 Org: User:
Start: 08/31/14 End: 04/16/26 Due: 04/16/27

Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment

Phase: N/A Priority: Normal
NCT ID: NCT06279013 Org: User:
Start: 10/14/24 End: 05/01/28 Due: 05/01/29

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04333537 Org: User:
Start: 09/23/20 End: 04/27/31 Due: 04/27/32

Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05050162 Org: User:
Start: 02/01/22 End: 02/09/26 Due: 02/09/27

Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05646316 Org: User:
Start: 12/07/22 End: 10/31/26 Due: 10/31/27

Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

Phase: N/A Priority: Normal
NCT ID: NCT05408845 Org: User:
Start: 03/03/23 End: 07/31/28 Due: 07/31/29

Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02713386 Org: User:
Start: 11/14/16 End: 05/22/24 Due: 05/22/25

Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT05095376 Org: User:
Start: 03/28/22 End: 08/08/26 Due: 08/08/27

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

Phase: N/A Priority: Normal
NCT ID: NCT05050084 Org: User:
Start: 12/06/21 End: 11/11/26 Due: 11/11/27